Skip to content

Topical Mitomycin C application in management of localized caustic esophageal stricture in children: A double-blinded randomized placebo-controlled trial

Topical Mitomycin C application in management of localized caustic esophageal stricture in pediatric age group: A double-blinded randomized placebo-controlled trial to assess number of dilatation needed by each group to achieve complete resolution of dysphagia

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000683831
Enrollment
40
Registered
2012-06-26
Start date
2008-01-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

this trial aims to prove the effect of local Mitomycin C application on caustic esophageal stricture as adjuvent therapy to endoscopic dilatation to prevent refibrosis and decrease incidence of stricture recurrence

Interventions

this trial aim to study the effect of topical Mitomycin C application on esophageal stricture site after dilating it endoscopically, aiming to decrease incidence of reccurrence and refibrosis. Mitomycin C dose is prepared to use a concentration of 0.4 mg/ml then piece of gauze soaked with this solution is applied on stricture site for 5 minutes. standard protocol is to do dilatation session every 2 weeks for 3 months then session every month for next 3 months each session of dilatation take abou

this trial aim to study the effect of topical Mitomycin C application on esophageal stricture site after dilating it endoscopically, aiming to decrease incidence of reccurrence and refibrosis. Mitomycin C dose is prepared to use a concentration of 0.4 mg/ml then piece of gauze soaked with this solution is applied on stricture site for 5 minutes. standard protocol is to do dilatation session every 2 weeks for 3 months then session every month for next 3 months each session of dilatation take about 10 minutes in the first session, dilation is done and assessment of stricture length is done in the second dilation session, dilatation followed by Mitomycin/placebo application is done "application take 5 minutes" in the following sessions, dilatation only is done

Sponsors

Ain Shams University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

All children with localized caustic esophageal stricture (< 3 cm in length as measured radiologically and confirmed by endoscopy

Exclusion criteria

long (> 3 cm) or multiple strictures patients underwent previous esophageal surgery corrosive induced esophageal perforation undilatable stricture patients known to have a hypersensitivity or contraindication for MMC

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026